<div class="welcome-screen" id="welcomeScreen">
    <div class="welcome-banner">
        <h1 id="welcome-title">Welcome to the glomerular injury page!</h1>
        <p id="welcome-description">Explore the kidneys.</p>
    </div>
    
    <!-- GENERAL INTRODUCTION TO KIDNEY ANATOMY & PHYSIOLOGY -->
  <div class="explanation-card">
    <h1>Introduction</h1>
    <p>The <b>kidneys</b> are retroperitoneal organs responsible for filtration, electrolyte balance, and endocrine functions. Each kidney contains ~1 million <b>nephrons</b>, the functional units composed of a <b>glomerulus</b> (capillary tuft) and a <b>tubular system</b>.</p>
    
    <h2>Glomerular Filtration Barrier</h2>
    <p>The <b>glomerular filtration barrier (GFB)</b> consists of three layers:</p>
    <ol>
      <li><b>Endothelium</b>: Fenestrated capillaries preventing cellular passage.</li>
      <li><b>Basement membrane</b>: Collagen/IV matrix with heparan sulfate (negative charge).</li>
      <li><b>Podocytes</b>: Interdigitating foot processes with slit diaphragms (nephrin proteins).</li>
    </ol>
    
    <p><b>Key physiology</b>: The GFB restricts molecules by <b>size</b> (≥70 kDa blocked) and <b>charge</b> (negative repels albumin). Disruption leads to proteinuria—a hallmark of nephrotic/nephritic syndromes.</p>
    
    <div class="mnemonic">
      <h4>Mnemonic: "FEBS" for Glomerular Barrier Layers</h4>
      <p><b>F</b>enestrated endothelium → <b>E</b>lectron-dense BM → <b>B</b>asement membrane → <b>S</b>lit diaphragm (podocytes)</p>
    </div>
  </div>

  <div class="question-card">
    <h1>Question 1</h1>
    <p>Which glomerular layer is primarily responsible for charge selectivity?</p>
    <ul class="options" id="options">
      <li data-answer="wrong">Fenestrated endothelium</li>
      <li data-answer="correct">Basement membrane</li>
      <li data-answer="wrong">Podocyte slit diaphragm</li>
    </ul>
  </div>

  <div class="question-card">
    <h1>Question 2</h1>
    <p>What protein is critical for maintaining podocyte foot processes?</p>
    <ul class="options" id="options">
      <li data-answer="wrong">Collagen IV</li>
      <li data-answer="correct">Nephrin</li>
      <li data-answer="wrong">Heparan sulfate</li>
    </ul>
  </div>

     <!-- PATHOPHYSIOLOGY OF NEPHROTIC vs. NEPHRITIC SYNDROMES -->
  <div class="explanation-card">
    <h1>Nephrotic vs. Nephritic Syndromes: Pathophysiological Basis of Clinical Differences</h1>
    
    <h2>Core Pathophysiological Mechanisms</h2>
    <p>The clinical divergence between nephrotic and nephritic syndromes stems from <b>distinct injury patterns</b> in the glomerulus:</p>
    
    <h3>1. Nephrotic Syndrome: Podocyte Injury and Permselectivity Loss</h3>
    <p>In nephrotic syndrome, the primary defect is <b>disruption of the glomerular filtration barrier's permselectivity</b>, particularly at the level of podocytes. Key mechanisms:</p>
    <ol>
      <li><b>Podocyte Foot Process Effacement</b>: 
        Structural collapse of podocyte foot processes (e.g., due to <b>nephrin</b> mutations in congenital nephrotic syndrome or <b>PLA2R antibodies</b> in membranous nephropathy). This widens filtration slits, allowing albumin loss.</li>
      <li><b>Loss of Charge Selectivity</b>: 
        Degradation of heparan sulfate proteoglycans in the basement membrane (e.g., in diabetic nephropathy) reduces negative charge repulsion, permitting <b>albuminuria</b>.</li>
      <li><b>Consequences of Proteinuria</b>: 
        Hypoalbuminemia → decreased oncotic pressure → edema; compensatory hepatic lipoprotein synthesis → <b>hyperlipidemia</b>.</li>
    </ol>
    <p><b>Histological hallmark</b>: Electron microscopy shows <b>foot process effacement</b> without inflammatory infiltrates.</p>

    <h3>2. Nephritic Syndrome: Inflammatory Glomerular Damage</h3>
    <p>Nephritic syndrome results from <b>immune-mediated inflammation</b> damaging the glomerular capillary walls, leading to:</p>
    <ol>
      <li><b>Immune Complex Deposition</b>:
        Subendothelial (e.g., lupus nephritis) or subepithelial (e.g., post-streptococcal GN) deposits activate complement (C5a) → <b>neutrophil recruitment</b> and protease release.</li>
      <li><b>Capillary Wall Disruption</b>:
        Inflammation compromises endothelial integrity, allowing <b>RBCs</b> and <b>fibrinogen</b> to leak into Bowman’s space (→ RBC casts).</li>
      <li><b>Proliferative Changes</b>:
        Mesangial/endothelial cell hyperplasia (e.g., IgA nephropathy) or crescent formation (RPGN) reduces glomerular blood flow → <b>azotemia</b> and <b>hypertension</b>.</li>
    </ol>
    <p><b>Histological hallmark</b>: Light microscopy shows <b>hypercellularity</b>, crescents, or neutrophilic infiltrates.</p>

    <div class="mnemonic">
      <h4>Mnemonic: "PORE" vs. "FIRE" for Pathophysiology</h4>
      <p>
        <b>PORE</b> (Nephrotic): <b>P</b>odocyte injury → <b>O</b>nly protein leaks → <b>R</b>efined charge/size selectivity loss → <b>E</b>dema.<br>
        <b>FIRE</b> (Nephritic): <b>F</b>ibrinoid necrosis → <b>I</b>nflammation → <b>R</b>BCs escape → <b>E</b>ndocapillary proliferation.
      </p>
    </div>
  </div>

  <div class="question-card">
    <h1>Question 3</h1>
    <p>Which mechanism is MOST characteristic of nephrotic syndrome?</p>
    <ul class="options" id="options">
      <li data-answer="wrong">Complement-mediated neutrophil recruitment</li>
      <li data-answer="correct">Podocyte foot process effacement</li>
      <li data-answer="wrong">Subendothelial immune complex deposition</li>
    </ul>
  </div>

    <!-- CLINICAL CORRELATIONS OF PATHOPHYSIOLOGY -->
    <div class="explanation-card">
        <h1>Why Nephrotic and Nephritic Syndromes Present Differently</h1>

        <h2>1. Proteinuria Severity</h2>
        <p>
            <b>Nephrotic</b>: Massive proteinuria (>3.5 g/day) occurs because podocyte injury creates <b>large pores</b>, but the basement membrane remains intact enough to prevent RBC leakage.<br>
            <b>Nephritic</b>: Subnephrotic proteinuria (<3.5 g/day) reflects <b>smaller "holes"</b> from focal capillary wall breaks, allowing limited protein but significant RBCs.
        </p>

        <h2>2. Hematuria</h2>
        <p>
            <b>Nephrotic</b>: Typically absent because inflammation doesn’t rupture capillaries. Microscopic hematuria may occur in advanced FSGS due to segmental scarring.<br>
            <b>Nephritic</b>: <b>Dysmorphic RBCs</b> result from RBCs squeezing through fractured basement membranes. RBC casts form when clots organize in tubules.
        </p>

        <h2>3. Hypertension/Azotemia</h2>
        <p>
            <b>Nephrotic</b>: Usually normotensive unless volume overloaded. GFR is preserved early (no occlusion).<br>
            <b>Nephritic</b>: Hypertension due to <b>renin release</b> from ischemic glomeruli (inflammation reduces flow). Azotemia occurs from <b>obstructed capillaries</b> (e.g., crescents).
        </p>

        <div class="mnemonic">
            <h4>Mnemonic: "Nephrotic Sells Protein, Nephritic Spills Blood"</h4>
            <p>Nephrotic = Selective <b>P</b>roteinuria | Nephritic = <b>P</b>urple (RBC) + <b>P</b>ressure (HTN).</p>
        </div>
    </div>

    <div class="question-card">
        <h1>Question 4</h1>
        <p>A patient presents with hypertension, hematuria, and a serum creatinine of 2.5 mg/dL. Urinalysis shows RBC casts. What is the MOST likely pathophysiology?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Podocyte foot process effacement</li>
            <li data-answer="correct">Endocapillary proliferation obstructing glomerular flow</li>
            <li data-answer="wrong">Heparan sulfate loss in the GBM</li>
        </ul>
    </div>

    <!-- HISTOLOGICAL DIFFERENCES -->
    <div class="explanation-card">
        <h1>Histological Correlation: Why Biopsy Matters</h1>

        <h2>Nephrotic Syndrome Patterns</h2>
        <ol>
            <li><b>Minimal Change Disease</b>: Normal light microscopy; EM shows foot process effacement.</li>
            <li><b>Membranous Nephropathy</b>: Thickened GBM with "spike-and-dome" appearance (IgG deposits).</li>
            <li><b>FSGS</b>: Segmental sclerosis (scarring) of glomeruli (tip, collapsing, or perihilar variants).</li>
        </ol>

        <h2>Nephritic Syndrome Patterns</h2>
        <ol>
            <li><b>Proliferative GN</b> (e.g., IgA nephropathy): Mesangial hypercellularity.</li>
            <li><b>Crescentic GN</b>: Cellular/fibrous crescents in Bowman’s space (RPGN).</li>
            <li><b>Post-Streptococcal GN</b>: Subepithelial "humps" on EM.</li>
        </ol>

        <p><b>Key point</b>: Nephritic lesions often show <b>C3/C4 deposition</b> (immunofluorescence), while nephrotic lesions may have <b>IgG</b> (membranous) or be <b>paucimmune</b> (FSGS).</p>
    </div>

    <div class="question-card">
        <h1>Question 5</h1>
        <p>Which finding is MOST specific for nephritic syndrome?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Heavy proteinuria (>3.5 g/day)</li>
            <li data-answer="correct">RBC casts on urinalysis</li>
            <li data-answer="wrong">Generalized edema</li>
        </ul>
    </div>

    <!-- COMPREHENSIVE NEPHROTIC SYNDROME SECTION -->
    <div class="explanation-card">
        <h1>Nephrotic Syndrome: Etiologies and Pathophysiology</h1>
        <p><b>Primary causes</b> (intrinsic glomerular disease):</p>
        <ol>
            <li><b>Minimal Change Disease (MCD)</b>: Podocyte foot process effacement (loss of nephrin). Most common in children.</li>
            <li><b>Focal Segmental Glomerulosclerosis (FSGS)</b>: Collapse of glomerular capillaries with scarring. Associated with HIV, obesity, or genetic mutations (e.g., TRPC6).</li>
            <li><b>Membranous Nephropathy</b>: Anti-PLA2R antibodies targeting podocytes. "Spike-and-dome" appearance on EM.</li>
        </ol>

        <h2>Secondary Causes</h2>
        <p>Systemic diseases (e.g., diabetes mellitus (Kimmelstiel-Wilson nodules), amyloidosis, lupus (class V)).</p>

        <div class="mnemonic">
            <h4>Mnemonic: "MDF" for Primary Nephrotic Causes</h4>
            <p><b>M</b>CD → <b>D</b>iabetes (secondary) → <b>F</b>SGS</p>
        </div>
    </div>

    <div class="question-card">
        <h1>Question 6</h1>
        <p>Which nephrotic syndrome etiology is most likely in a child with sudden onset edema and selective proteinuria (mostly albumin)?</p>
        <ul class="options" id="options">
            <li data-answer="correct">Minimal Change Disease</li>
            <li data-answer="wrong">Membranous Nephropathy</li>
            <li data-answer="wrong">FSGS</li>
        </ul>
    </div>

    <div class="explanation-card">
        <h1>Diagnostics for Nephrotic Syndrome</h1>
        <p>Diagnosis relies on <b>urinalysis, blood tests, and kidney biopsy</b> when etiology is unclear:</p>
        
        <h2>1. Urinalysis & Protein Quantification</h2>
        <p><b>Key findings:</b></p>
        <ol>
            <li><b>Proteinuria (>3.5 g/day)</b>: Confirmed via 24-hour urine collection or spot urine protein-to-creatinine ratio (UPCR >3.5).</li>
            <li><b>Hypoalbuminemia (<3 g/dL)</b>: Due to urinary loss and impaired hepatic synthesis.</li>
            <li><b>Lipiduria</b>: Oval fat bodies/Maltese crosses under polarized light.</li>
        </ol>
        
        <h2>2. Serologic Workup</h2>
        <p>To identify secondary causes:</p>
        <ol>
            <li><b>Anti-PLA2R antibodies</b> (Membranous nephropathy).</li>
            <li><b>HIV/HBV/HCV serology</b> (FSGS-associated).</li>
            <li><b>ANA, anti-dsDNA</b> (Lupus nephritis).</li>
        </ol>
        
        <h2>3. Kidney Biopsy</h2>
        <p>Indicated if:</p>
        <ol>
            <li>Adult-onset (unlike pediatric MCD, which is steroid-responsive).</li>
            <li>Suspected secondary cause (e.g., amyloidosis).</li>
            <li>Steroid resistance.</li>
        </ol>
    </div>
    
    <div class="question-card">
        <h1>Question 7</h1>
        <p>Which finding on urinalysis is MOST suggestive of nephrotic syndrome?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Dysmorphic RBCs</li>
            <li data-answer="correct">Maltese crosses under polarized light</li>
            <li data-answer="wrong">White cell casts</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>Treatment of Nephrotic Syndrome</h1>
        <p>Management targets <b>proteinuria reduction</b> and <b>complication prevention</b>:</p>
        
        <h2>1. Primary Therapy (Disease-Specific)</h2>
        <ol>
            <li><b>Minimal Change Disease (MCD)</b>: High-dose <b>glucocorticoids</b> (90% respond). Relapses may require cyclophosphamide/rituximab.</li>
            <li><b>FSGS</b>: Steroids + <b>calcineurin inhibitors</b> (tacrolimus/cyclosporine).</li>
            <li><b>Membranous Nephropathy</b>: Anti-PLA2R+ cases may respond to <b>rituximab</b> or cyclophosphamide + steroids.</li>
        </ol>
        
        <h2>2. Supportive Care</h2>
        <ol>
            <li><b>ACE inhibitors/ARBs</b>: Reduce proteinuria and slow CKD progression.</li>
            <li><b>Statins</b>: For hyperlipidemia (increased CVD risk).</li>
            <li><b>Diuretics</b>: For edema (avoid NSAIDs—worsen AKI).</li>
        </ol>
        
        <div class="mnemonic">
            <h4>Mnemonic: "STEReOID" for Steroid-Sensitive Nephrotic Causes</h4>
            <p><b>S</b>teroids work in → <b>T</b>ip-lesion FSGS (some cases) → <b>E</b>osinophilic MCD → <b>R</b>apid responders (kids).</p>
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 8</h1>
        <p>Which patient is LEAST likely to require a kidney biopsy for nephrotic syndrome?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">A 45-year-old with nephrotic-range proteinuria and hematuria</li>
            <li data-answer="correct">A 5-year-old with edema and selective proteinuria</li>
            <li data-answer="wrong">A 60-year-old with monoclonal gammopathy</li>
        </ul>
    </div>

    <div class="explanation-card">
        <h1>Diagnostics for Nephritic Syndrome</h1>
        <p>Focused on <b>identifying inflammation</b> and underlying etiology:</p>
        
        <h2>1. Urinalysis & Microscopy</h2>
        <ol>
            <li><b>Dysmorphic RBCs</b> (glomerular origin).</li>
            <li><b>RBC casts</b> (pathognomonic for glomerulonephritis).</li>
            <li><b>Subnephrotic proteinuria</b> (<3.5 g/day).</li>
        </ol>
        
        <h2>2. Serologic Workup</h2>
        <ol>
            <li><b>Anti-GBM antibodies</b> (Goodpasture’s syndrome).</li>
            <li><b>Low C3/C4</b> (Post-streptococcal GN, lupus).</li>
            <li><b>ANCA</b> (MPO- or PR3-positive in vasculitis).</li>
        </ol>
        
        <h2>3. Kidney Biopsy</h2>
        <p><b>Essential</b> for definitive diagnosis. Key findings:</p>
        <ol>
            <li><b>Diffuse proliferative GN</b> (lupus, PSGN).</li>
            <li><b>Crescents</b> (RPGN, e.g., ANCA vasculitis).</li>
        </ol>
    </div>
    
    <div class="question-card">
        <h1>Question 9</h1>
        <p>Which serologic finding suggests post-streptococcal GN?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">Anti-PLA2R antibodies</li>
            <li data-answer="correct">Low C3 with elevated ASO titers</li>
            <li data-answer="wrong">Positive ANCA</li>
        </ul>
    </div>
    
    <div class="explanation-card">
        <h1>Treatment of Nephritic Syndrome</h1>
        <p>Targets <b>immune suppression</b> and <b>preventing ESRD</b>:</p>
        
        <h2>1. Disease-Specific Therapy</h2>
        <ol>
            <li><b>Post-Streptococcal GN</b>: Supportive care (usually self-limiting).</li>
            <li><b>Lupus Nephritis</b>: High-dose <b>steroids + mycophenolate/cyclophosphamide</b>.</li>
            <li><b>ANCA Vasculitis</b>: <b>Rituximab</b> or cyclophosphamide + steroids.</li>
            <li><b>Anti-GBM Disease</b>: <b>Plasmapheresis</b> + cyclophosphamide.</li>
        </ol>
        
        <h2>2. Supportive Care</h2>
        <ol>
            <li><b>Blood pressure control</b> (ACEi/ARBs preferred).</li>
            <li><b>Dialysis</b> if RPGN with oligoanuria.</li>
        </ol>
        
        <div class="mnemonic">
            <h4>Mnemonic: "CRESCENT" for RPGN Causes</h4>
            <p><b>C</b>3/4 low (lupus) → <b>R</b>apid decline → <b>E</b>ndocapillary proliferation → <b>S</b>trep infection → <b>C</b>ANCA/PR3 → <b>E</b>xtracapillary crescents → <b>N</b>ecrotizing GN → <b>T</b>arget anti-GBM.</p>
        </div>
    </div>
    
    <div class="question-card">
        <h1>Question 10</h1>
        <p>Which treatment is MOST urgent in a patient with anti-GBM disease and hemoptysis?</p>
        <ul class="options" id="options">
            <li data-answer="wrong">High-dose steroids alone</li>
            <li data-answer="correct">Plasmapheresis + cyclophosphamide</li>
            <li data-answer="wrong">Mycophenolate mofetil</li>
        </ul>
    </div>      

    <div class="placeholder" id="empty">Test</div>

</div>